Exploiting radiation immunostimulatory effects to improve glioblastoma outcome
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noac239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Hala Awada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CRCI2NA, INSERM, CNRS, F-44000 Nantes, France. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ERASMUS, SAFAR, ARC Foundation.
Abstract (Originalsprache)
Cancer treatment protocols depend on tumor type, localization, grade, and patient. Despite aggressive treatments, median survival of patients with Glioblastoma (GBM), the most common primary brain tumor in adults, does not exceed 18 months, and all patients eventually relapse. Thus, novel therapeutic approaches are urgently needed. Radiotherapy (RT) induces a multitude of alterations within the tumor ecosystem, ultimately modifying the degree of tumor immunogenicity at GBM relapse. The present manuscript reviews the diverse effects of RT radiotherapy on tumors, with a special focus on its immunomodulatory impact to finally discuss how RT could be exploited in GBM treatment through immunotherapy targeting. Indeed, while further experimental and clinical studies are definitively required to successfully translate preclinical results in clinical trials, current studies highlight the therapeutic potential of immunotherapy to uncover novel avenues to fight GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nantes Université, CRCI2NA, INSERM, CNRS, F-44000 Nantes, France.
- Anti-Tumor Therapeutic Targeting Laboratory, Faculty of Sciences, Lebanese University, Hadath, Beirut, Lebanon.
- Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
ORCID-Profile: François Paris, Claire Pecqueur
Förderung
- ERASMUS
- SAFAR
- ARC Foundation
- Ligue contre le Cancer
Zitieren
APA
Awada, H., Paris, F., & Pecqueur, C. (2023). Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Neuro-Oncology. https://doi.org/10.1093/neuonc/noac239
Vancouver
Awada H, Paris F, Pecqueur C. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Neuro-Oncology. 2023. doi:10.1093/neuonc/noac239
BibTeX
@article{Awada2023,
author = {Awada, Hala and Paris, François and Pecqueur, Claire},
title = {Exploiting radiation immunostimulatory effects to improve glioblastoma outcome},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noac239}
}
EUVIMED